Northern Trust Corp An2 Therapeutics, Inc. Transaction History
Northern Trust Corp
- $600 Billion
- Q3 2024
A detailed history of Northern Trust Corp transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 32,595 shares of ANTX stock, worth $38,136. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,595
Previous 32,595
-0.0%
Holding current value
$38,136
Previous $70,000
51.43%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ANTX
# of Institutions
33Shares Held
13.7MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5.75MShares$6.73 Million3.62% of portfolio
-
Ra Capital Management, L.P. Boston, MA2MShares$2.34 Million0.03% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.56MShares$1.82 Million0.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.22 Million0.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY579KShares$677,2250.79% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $22.7M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...